{"entities":{"Q151589":{"pageid":153125,"ns":120,"title":"Item:Q151589","lastrevid":84770630,"modified":"2026-06-01T13:41:38Z","type":"item","id":"Q151589","labels":{"en":{"language":"en","value":"A predictive probability design for phase II cancer clinical trials"}},"descriptions":{"en":{"language":"en","value":"scientific article"}},"aliases":{},"claims":{"P31":[{"mainsnak":{"snaktype":"value","property":"P31","hash":"fd5912e4dab4b881a8eb0eb27e7893fef55176ad","datavalue":{"value":{"entity-type":"item","numeric-id":56887,"id":"Q56887"},"type":"wikibase-entityid"},"datatype":"wikibase-item"},"type":"statement","id":"Q151589$B39EC976-7C4B-4CF2-80DD-89F055679E60","rank":"normal"}],"P27":[{"mainsnak":{"snaktype":"value","property":"P27","hash":"3fa6ddf4b432e087c3e4f7da2cf8300cf5553ca6","datavalue":{"value":"10.1177/1740774508089279","type":"string"},"datatype":"external-id"},"type":"statement","id":"Q151589$CB26FA03-CD1A-4C8D-8902-93F03C082AB1","rank":"normal"}],"P200":[{"mainsnak":{"snaktype":"value","property":"P200","hash":"f2b672ca610bdac042f3f8eb8336abdcaf511455","datavalue":{"value":{"entity-type":"item","numeric-id":57852,"id":"Q57852"},"type":"wikibase-entityid"},"datatype":"wikibase-item"},"type":"statement","id":"Q151589$1E8217D5-42B4-415F-86A1-FD4FA06474EA","rank":"normal"}],"P26":[{"mainsnak":{"snaktype":"value","property":"P26","hash":"5412d66313a7865b584c17c89e6ea8f1b0c53594","datavalue":{"value":"5","type":"string"},"datatype":"string"},"type":"statement","id":"Q151589$867B2660-91FE-4E3C-AAA8-9FA760384D8A","rank":"normal"}],"P25":[{"mainsnak":{"snaktype":"value","property":"P25","hash":"b8f23e21c54d542f784defaef10454ba7971b38a","datavalue":{"value":"2","type":"string"},"datatype":"string"},"type":"statement","id":"Q151589$2B5E4327-BDE6-4044-A2CC-BAD8BCA1E00C","rank":"normal"}],"P128":[{"mainsnak":{"snaktype":"value","property":"P128","hash":"31840c0ac806c94671656a6f01bea40a946f70ff","datavalue":{"value":"93-106","type":"string"},"datatype":"string"},"type":"statement","id":"Q151589$A18566D8-C0D4-4FD8-A283-14B33B5C0DB7","rank":"normal"}],"P28":[{"mainsnak":{"snaktype":"value","property":"P28","hash":"19b8f2af7f0986c9c462b75f4a8bfb541c843b8d","datavalue":{"value":{"time":"+2008-03-28T00:00:00Z","timezone":0,"before":0,"after":0,"precision":11,"calendarmodel":"http://www.wikidata.org/entity/Q1985727"},"type":"time"},"datatype":"time"},"type":"statement","id":"Q151589$9E88C7FA-AF25-4E76-86B6-B74209BC0CFB","rank":"normal"}],"P12":[{"mainsnak":{"snaktype":"value","property":"P12","hash":"ecacd8d08ed5ad84f6b9b515c6f0ba0c04407555","datavalue":{"value":"Q42109216","type":"string"},"datatype":"external-id"},"type":"statement","id":"Q151589$B1CEBB0E-3EDA-4E84-B1AD-32FDCF45F763","rank":"normal"}],"P1460":[{"mainsnak":{"snaktype":"value","property":"P1460","hash":"57f7fea50d2ce1b39b695c4a1313582eed405e38","datavalue":{"value":{"entity-type":"item","numeric-id":5976449,"id":"Q5976449"},"type":"wikibase-entityid"},"datatype":"wikibase-item"},"type":"statement","id":"Q151589$ACA5C427-ECC3-4506-9F3C-1D855D88FFA5","rank":"normal"}],"P43":[{"mainsnak":{"snaktype":"value","property":"P43","hash":"d57b270ed985ad6dfeefb7813ed76e1c80989966","datavalue":{"value":"J Jack Lee","type":"string"},"datatype":"string"},"type":"statement","id":"Q151589$3E630EEA-D140-4073-A65A-6FEB891E9C49","rank":"normal"},{"mainsnak":{"snaktype":"value","property":"P43","hash":"3e47636d7dbf43663eb117308da5344ee4a41f4e","datavalue":{"value":"Diane D Liu","type":"string"},"datatype":"string"},"type":"statement","id":"Q151589$9CB0F44D-628C-4DBA-93F2-2127B0CB4CD1","rank":"normal"}]},"sitelinks":{"mardi":{"site":"mardi","title":"A predictive probability design for phase II cancer clinical trials","badges":[],"url":"https://portal.mardi4nfdi.de/wiki/A_predictive_probability_design_for_phase_II_cancer_clinical_trials"}}}}}